Research Study

A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD) (PCYC-1140-IM)
Principal Investigator 
Raewyn Broady

Overview

Study Start/End 
Oct 12, 2017 to Mar 31, 2020
Locations 
Vancouver General Hospital
Name/Title 
Mabel Ma
Phone 
604-875-4111 ext.22948
Purpose of Study 

To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.